Amgen to Acquire Horizon Therapeutics for $27.8 Billion
- December 16, 2022
Biotech drug firm Amgen Inc. is looking to expand its portfolio of medicines that treat rare diseases by acquiring Horizon Therapeutics Plc for roughly $27.8 billion, the companies announced December 12.
ARTICLE TAGS
You must be logged in to access this content.